{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-087284","form_type":"8-K","ticker":"TERN","cik":"0001831363","company_name":"Terns Pharmaceuticals, Inc.","filed_at":"2024-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.771122+00:00","generated_at":"2026-05-31T15:46:06.201485+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Terns appoints new Chief Legal Officer; CFO and General Counsel to depart in planned transitions","bullets":["Elona Kogan appointed Chief Legal Officer effective July 29; previously CLO at Seer, Inc.","CFO Mark Vignola to leave by Feb 1, 2025 or upon successor; receives $475k severance plus $500k retention bonus.","General Counsel Bryan Yoon steps down, becomes COO/Special Counsel until Sep 3, 2024; receives $490,700 severance.","Search for new CFO underway; Vignola and Yoon remain in transition roles."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-087284","json":"https://secwatch.observer/filing/0000950170-24-087284.json","markdown":"https://secwatch.observer/filing/0000950170-24-087284.md","text":"https://secwatch.observer/filing/0000950170-24-087284.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/tern-20240723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:46:06.201485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b141b8c4c","claim":"Mark Vignola departed as Chief Financial Officer at Terns Pharmaceuticals, Inc..","evidence_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","confidence":0.95},{"claim_id":"1cab0a561c","claim":"Bryan Yoon changed role as General Counsel at Terns Pharmaceuticals, Inc..","evidence_excerpt":"Effective upon the execution of the Yoon Separation Agreement, Mr. Yoon has assumed the title of Chief Operating Officer and Special Counsel and has ceased to serve as General Counsel and Secretary of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","confidence":0.95},{"claim_id":"5175d4122f","claim":"Bryan Yoon departed as Chief Operating Officer at Terns Pharmaceuticals, Inc..","evidence_excerpt":"The Yoon Separation Agreement provides for Mr. Yoon’s continued service as Chief Operating Officer and Special Counsel for a transition period until September 3, 2024 (the “Yoon Separation Date”). Mr. Yoon’s employment will terminate and he will cease to hold any positions with the Company as of the Yoon Separation Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001193125-26-251709","ticker":"CRVL","company_name":"CORVEL CORP","filed_at":"2026-06-01T21:05:42+00:00","headline":"CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251709","json":"https://secwatch.observer/filing/0001193125-26-251709.json","markdown":"https://secwatch.observer/filing/0001193125-26-251709.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/874866/000119312526251709/0001193125-26-251709-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874866/000119312526251709/d24231d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","comparable_excerpt":"In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/874866/000119312526251709/0001193125-26-251709-index.htm"}},{"accession":"0000105770-26-000080","ticker":"WST","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2026-06-01T20:32:30+00:00","headline":"West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-26-000080","json":"https://secwatch.observer/filing/0000105770-26-000080.json","markdown":"https://secwatch.observer/filing/0000105770-26-000080.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/wst-20260531.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","comparable_excerpt":"As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm"}},{"accession":"0000060519-26-000024","ticker":"LPX","company_name":"LOUISIANA-PACIFIC CORP","filed_at":"2026-06-01T20:31:12+00:00","headline":"LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000060519-26-000024","json":"https://secwatch.observer/filing/0000060519-26-000024.json","markdown":"https://secwatch.observer/filing/0000060519-26-000024.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/60519/000006051926000024/0000060519-26-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/60519/000006051926000024/lpx-20260527.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","comparable_excerpt":"On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/60519/000006051926000024/0000060519-26-000024-index.htm"}},{"accession":"0001193125-26-251467","ticker":"PENG","company_name":"Penguin Solutions, Inc.","filed_at":"2026-06-01T20:17:28+00:00","headline":"Penguin Solutions CFO Nate Olmstead to step down; Aaron Johnson named interim CFO; reaffirms FY2026 guidance at high end","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251467","json":"https://secwatch.observer/filing/0001193125-26-251467.json","markdown":"https://secwatch.observer/filing/0001193125-26-251467.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616533/000119312526251467/0001193125-26-251467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616533/000119312526251467/d104493d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","comparable_excerpt":"On May 31, 2026, the board of directors of the Company appointed Aaron Johnson, the Company’s Vice President, Finance and Accounting, as interim CFO and as the Company’s principal financial and accounting officer, succeeding Mr. Olmstead in these positions effective as of July 9, 2026, on an interim basis until the Company appoints a successor.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1616533/000119312526251467/0001193125-26-251467-index.htm"}},{"accession":"0002064307-26-000007","ticker":"LOGC","company_name":"ContextLogic Holdings Inc.","filed_at":"2026-06-01T20:15:17+00:00","headline":"ContextLogic appoints Scott Stewart as CFO & COO effective June 1; interim CFO resigns","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0002064307-26-000007","json":"https://secwatch.observer/filing/0002064307-26-000007.json","markdown":"https://secwatch.observer/filing/0002064307-26-000007.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2064307/000206430726000007/0002064307-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2064307/000206430726000007/logc-20260529.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","comparable_excerpt":"On June 1, 2026 the Company also announced the appointment of Scott Stewart, age 53, as Chief Financial Officer and Chief Operating Officer, effective June 1, 2026 (the “Effective Date”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2064307/000206430726000007/0002064307-26-000007-index.htm"}},{"accession":"0000927089-26-000101","ticker":"MGNO","company_name":"Magnolia Bancorp, Inc.","filed_at":"2026-06-01T18:15:36+00:00","headline":"Magnolia Bancorp names Robert Kimbro President/CEO; Hurley becomes Executive Chair","event_type":"leadership","sec_items":["5.02","5.07","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000927089-26-000101","json":"https://secwatch.observer/filing/0000927089-26-000101.json","markdown":"https://secwatch.observer/filing/0000927089-26-000101.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2033615/000092708926000101/0000927089-26-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2033615/000092708926000101/mban20260520_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","comparable_excerpt":"On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2033615/000092708926000101/0000927089-26-000101-index.htm"}},{"accession":"0001193125-26-250020","ticker":"NSC","company_name":"NORFOLK SOUTHERN CORP","filed_at":"2026-06-01T13:15:16+00:00","headline":"Norfolk Southern COO John Orr resigns; Brian Barr appointed successor effective June 1","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-250020","json":"https://secwatch.observer/filing/0001193125-26-250020.json","markdown":"https://secwatch.observer/filing/0001193125-26-250020.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/702165/000119312526250020/0001193125-26-250020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/702165/000119312526250020/d91653d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","comparable_excerpt":"On May 31, 2026, John Orr, Executive Vice President & Chief Operating Officer of Norfolk Southern Corporation (the “Company”), notified the Company of his intention to resign from the Company for “good reason” on account of proposed changes in the Company’s operations that would result in a diminution of his duties and responsibilities.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/702165/000119312526250020/0001193125-26-250020-index.htm"}},{"accession":"0001493152-26-026537","ticker":"FUSE","company_name":"Fusemachines Inc.","filed_at":"2026-06-01T12:18:34+00:00","headline":"Fusemachines appoints AI pioneer Dr. Julia Hirschberg to board; Shrestha resigns","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 7.01, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026537","json":"https://secwatch.observer/filing/0001493152-26-026537.json","markdown":"https://secwatch.observer/filing/0001493152-26-026537.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2033383/000149315226026537/0001493152-26-026537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2033383/000149315226026537/form8-k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017024087284/0000950170-24-087284-index.htm","comparable_excerpt":"Effective May 31, 2026, the board of directors (the “Board”) of Fusemachines Inc., a Delaware corporation (the “Company” or “Fusemachines”), following the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Julia Hirschberg as a member of the Board as a Class II director, until the Company’s 2027 annual meeting of stockholders or until Ms. Hirschberg’s successor is duly elected and qualified.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2033383/000149315226026537/0001493152-26-026537-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}